You are here

Abattis Bioceuticals Corp.

Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
ATT
CSE Index: 
Currency: 

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQB: ATTBF) (CSE: ATT), specialty biotechnology company with capabilities through its wholly-owned subsidiaries as a botanical drug development company that develops and licenses natural health products, medicines, extractions and ingredients for the biologics, nutraceutical, bioceutical and cosmetic markets, some of which will contain cannabinoid compounds. Abattis develops and is in the process of commercializing natural health products that target ailments and satisfy important market needs. Abattis is conducting ongoing research and development to create plant-based intellectual property and ingredients. Current areas of focus are growth through acquisition and business development and cash flow through commercialization of existing assets. The Company has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. Abattis follows strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions. For more information, visit the Company's website at: www.abattis.com.

You are here

Abattis Bioceuticals Corp. (ATT)

SEDAR Information

Company Info

Address
1200 - 625 Howe Street
Vancouver, BC V6C 2M6
Canada
Phone
604-674-8232
Email
news@abattis.com
Website
http://www.abattis.com
Listing date
Thursday, December 23, 2010
Transfer Agent
Computershare Investor Services Inc.
Auditor
NVS Chartered Accountants

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
477,804,139
Reserved for Issuance: 
0

Bulletins

12/02/2021

2021-0227 - Delist - Abattis Bioceuticals Corp. (ATT)

Le 12 février/February 2021

The common shares of Abattis Bioceuticals Corp. will be delisted at the market close today February 12, 2021.

Abattis Bioceuticals is currently suspended. See bulletin 2019-0810.

___________________

Les actions ordinaires de Abattis Bioceuticals Corp. seront radiées à la clôture du marché aujourd'hui le 12 février 2021.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2021-04-22-Earth-Day_Website.jpg

The CSE Celebrates: Earth Day!

Thursday, April 22, 2021 -
4:00pm to 5:00pm